EP.12H.01 A Phase 2 Study to Assess BDTX-1535, An Oral EGFR Inhibitor, in Patients with Non-Small Cell Lung Cancer
Patel, J., Spira, A., Stevenson, J., Chen, H., Baik, C., Gordon, S., Henry, J.T., Ahluwalia, M., Barve, M., Huang, C., Edenfield, J., Johnson, M., Eathiraj, S., Hajdenberg, J., Yurasov, S., Yu, H.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: Results of a phase III, single-dose trial versus dolasetron
EISENBERG, Peter, FIGUEROA-VADILLO, Jazmin, ZAMORA, Rosalio, CHARU, Veena, HAJDENBERG, Julio, CARTMELL, Alan, MACCIOCCHI, Alberto, GRUNBERG, Steven
Published in Cancer (01.12.2003)
Published in Cancer (01.12.2003)
Get full text
Journal Article
Sacituzumab govitecan (IMMU-132) for patients with pretreated metastatic urothelial uancer (UC): interim results
Tagawa, S.T., Faltas, B., Lam, E., Saylor, P., Bardia, A., Hajdenberg, J., Morgans, A.K., Lim, E., Kalinsky, K., Petrylak, D.P., Guarino, M., Galsky, M.D., Maliakal, P., Mudenda, B., Sharkey, R., Wegener, W., Goldenberg, D.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
A randomized phase II study of bone-targeted therapy in advanced androgen-dependent prostate cancer
Bilen, M. A., Liu, D., Mathew, P., Pagliaro, L. C., Logothetis, C., Araujo, J. C., Aparicio, A., Corn, P. G., Hajdenberg, J., Dakhil, S. R., Tu, S.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A phase II multicenter evaluation of ARQ 197 monotherapy in patients with relapsed or refractory germ cell tumors (GCTs)
Feldman, D. R., Einhorn, L. H., Quinn, D. I., Horwich, A., Loriot, Y., Joffe, J. K., Vaughn, D. J., Flechon, A., Hajdenberg, J., Pande, A. U., Liu, K., Gorbatchevsky, I., Motzer, R. J.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification
Leonard, J., Reeves, J., Ferhanoglu, B., Doner, K. T., Eom, H., Flinn, I. W., Raposo, J., Chowhan, N. M., Suh, C., Noga, S., Tumyan, G., Aung, S., Hajdenberg, J., Ulrich, B. K., Pendergrass, K. B., Mulligan, G., Rizo, A., Kussick, S., Offner, F.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Evaluation of VEGF targeted therapy efficacy in mRCC after sorafenib failure or intolerance
Hajdenberg, J., Oberoi, S., Cohen, N., Kayaleh, O., Harding, D., Tseng, J.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Safety and efficacy in patients (pts) with prior bevacizumab (BEV) treatment
Drabkin, H. A., Figlin, R. A., Stadler, W. M., Hutson, T. E., Hajdenberg, J., Chu, L., Trent, D., Campos, L. T., Kelly, F., Bukowski, R. M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Palonosetron (PALO) plus aprepitant (APREP) and dexamethasone (DEX) for the prevention of chemotherapy-induced nausea and vomiting (CINV) after emetogenic chemotherapy (CT)
Grote, T., Hajdenberg, J., Cartmell, A., Ferguson, S., Ginkel, A., Gallagher, S., Charu, V.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Palonosetron (PALO) plus aprepitant (APREP) and dexamethasone (DEX) for the prevention of chemotherapy-induced nausea and vomiting (CINV) after emetogenic chemotherapy (CT)
Grote, T., Hajdenberg, J., Cartmell, A., Ferguson, S., Ginkel, A., Gallagher, S., Charu, V.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Abstract CT064: Treatment for metastatic platinum-resistant urothelial cancer (PRUC) with an anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): phase I/II clinical experience
Tagawa, Scott T., Faltas, Bishoy, Lam, Elaine, Messersmith, Wells A., Saylor, Philip, Bardia, Aditya, Hajdenberg, Julio J., Morgans, Alicia K., Berlin, Jordan D., Lim, Emerson, Kalinsky, Kevin, Maliakal, Pius, Sharkey, Robert M., Wilhelm, Francois, Goldenberg, David M., Ocean, Allyson J.
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article